Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.63 USD | -0.26% | +5.00% | -9.03% |
Apr. 17 | IGM Biosciences, Sanofi Narrow Partnership to Focus on Potential Immunology and Inflamation Targets | MT |
Apr. 17 | IGM Biosciences, Inc. Announces Refocusing of Sanofi Collaboration | CI |
Evolution of the average Target Price on IGM Biosciences, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering IGM Biosciences, Inc.
HC Wainwright | |
RBC Capital Markets | |
BofA Securities | |
Wedbush | |
Morgan Stanley | |
Stifel Nicolaus | |
JPMorgan Chase | |
Truist Securities | |
Jefferies & Co. | |
Baird | |
Guggenheim |
EPS Revisions
- Stock Market
- Equities
- IGMS Stock
- Consensus IGM Biosciences, Inc.